DHG Pharma

What DHG Pharma does

DHG Pharma (Công ty Cổ phần Dược Hậu Giang) is a Vietnamese pharmaceutical manufacturer and distributor headquartered in Cần Thơ, Vietnam, and publicly listed on the Ho Chi Minh City Stock Exchange (HOSE) under ticker symbol DHG. Founded in 1974, the company employs 1,001-5,000 staff and operates its own nationwide distribution system (Hệ thống phân phối) reaching pharmacies and healthcare providers across the country. DHG Pharma manufactures and distributes a broad portfolio of pharmaceutical products and health supplements spanning pain relief and fever reduction (HAPACOL 250, HAPACOL 650), digestive health (Biofermin, NATTO DHA / Natto Enzym), immune support and supplements (Bocalex, Bocalex Multi), allergy treatment (Telfor), antibacterial products (Bioskin), and a wide range of generic essential medicines covering anti-inflammatory, cardiovascular, neurological, ENT, vitamins, antifungals, and ophthalmic therapeutic categories. Major brands are supported by dedicated consumer-facing websites (hapacol.vn, telfor.vn, nattoenzym.vn, bocalex.vn, biofermin.vn).

The business operates on a sales-led, horizontal-segmentation go-to-market model. Revenue is generated primarily through the company's own direct distribution network selling to pharmacies and healthcare providers (primary segment) and to end consumers via OTC and supplement purchases (secondary segment). Pricing is not publicly disclosed and is shaped by the regulated Vietnamese pharmaceutical pricing environment. Marketing is multi-channel, combining a corporate website, brand-specific websites, YouTube, Facebook, LinkedIn, and community health programs that double as brand-building activities, including free medical examinations, medicine donations, and large-scale CSR campaigns (notably a 12+ tỷ đồng COVID-19 response and recurring disaster-relief distributions). Customer engagement is reinforced through a loyalty program with quarterly prize draws held across branch cities such as Nha Trang. Operations are concentrated entirely in Vietnam with no disclosed international footprint, and the company is governed through standard public-company disclosures including shareholder meetings, annual reports, and corporate governance reports available on its website.

Name

DHG Pharma

Legal name

Công ty Cổ phần Dược Hậu Giang

Website

https://dhgpharma.com.vn

Company type

Public

Founded year

2004

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

DHG Pharma is a publicly listed Vietnamese pharmaceutical manufacturer and distributor headquartered in Cần Thơ, Vietnam, producing prescription medicines, OTC drugs, and health supplements through its own nationwide distribution network serving pharmacies, healthcare providers, and end consumers.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience) (CRAOAHAG)

akta.pro secondary industries

Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA), Vitamins & Minerals (Single Nutrients) (CRADAGAB), Third-Party Logistics (3PL) & Warehousing for Pharmaceuticals (HLAIAJAL)

Keywords

• Generic pharmaceuticals
• Over-the-counter medicines
• Health supplements
• Drug distribution
• Essential medicines

Headquarters

HQ city

Can Tho

HQ country

Vietnam

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

DHG Pharma manufactures and distributes generic pharmaceutical products including prescription medicines, over-the-counter drugs, and health supplements across therapeutic categories such as pain relief, digestive health, antibacterial, cardiovascular, neurological, and vitamins/minerals. The company operates its own nationwide distribution system in Vietnam through branded product lines including Hapacol (pain/fever), Telfor (allergy), Bocalex (nutritional supplement), NATTO DHA/Natto Enzym (digestive health), DHG-Biofermin (probiotics), and Bioskin (antibacterial). Revenue for fiscal year 2023 was approximately 3.834 trillion VND.

Product overview

DHG Pharma is a Vietnamese pharmaceutical company that manufactures and distributes a comprehensive portfolio of essential medicines and health supplements. The company operates under multiple branded product lines including Telfor, Bocalex, NATTO DHA/Natto Enzym, HAPACOL (in 250mg and 650mg variants), Biofermin, and Bioskin. The product portfolio spans therapeutic categories including pain relief/fever reduction (HAPACOL), digestive health (Biofermin, Natto Enzym, Bocalex), antibacterial products (Bioskin), and broad-spectrum essential medicines covering anti-inflammatory, cardiovascular, neurological, and other therapeutic areas. The company maintains a nationwide distribution system and engages in community health outreach programs.

Differentiator

Problem solved

Functional benefit

Brands

• Telfor: Pharmaceutical brand under DHG Pharma, featured as a prominent brand
• Bocalex
• NATTO DHA
• Hapacol
• DHG-Biofermin
• Bioskin

Products and services

• Generic Essential Medicines Broad portfolio of generic prescription and over-the-counter medicines covering anti-inflammatory drugs, pain relief, fever reducers, ENT medications, allergy medications, antibiotics, cardiovascular drugs, neurological medications, vitamins, minerals, digestive aids, liver medications, antifungals, and eye drops. Sold through pharmacies and healthcare providers across Vietnam.
• Hapacol (Pain Relief / Fever Reduction) Over-the-counter brand for pain relief and fever reduction. Includes 250mg and 650mg dosage variants (Hapacol 250 and Hapacol 650). Targeted at Vietnamese consumers and pharmacies.
• Telfor (Allergy Medication) Pharmaceutical brand under DHG Pharma positioned for allergy treatment. Distributed through the company's nationwide network to pharmacies and end consumers.
• Bocalex (Nutritional Supplement) Nutritional/health supplement brand under DHG Pharma. Includes the Bocalex Multi variant formulated for immune system enhancement. Sold through pharmacies and consumer health channels.
• NATTO DHA / Natto Enzym (Digestive Health Supplement) Digestive health supplement brand under DHG Pharma featuring NATTO enzyme products. Positioned for cardiovascular and digestive health support; distributed through pharmacies across Vietnam.
• DHG-Biofermin (Probiotic Supplement) Probiotic digestive health supplement brand under DHG Pharma. Distributed through pharmacies for consumers seeking digestive/gut health support.
• Bioskin (Antibacterial Hand Gel) Antibacterial hand gel product containing nano silver and natural essential oils. Part of DHG Pharma's consumer health portfolio and used in community pandemic response programs.
• Ivis Salty (Eye Drops) Eye drop product used for preventing red eye conditions; distributed through DHG Pharma's pharmacy network and disaster relief programs.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Pymepharco JSC: Pymepharco is a HOSE-listed Vietnamese pharmaceutical company producing branded generics, with own manufacturing and distribution across Vietnam — directly comparable to DHG in scale, product mix, and channel strategy.
• Traphaco JSC: Traphaco is a leading HOSE-listed Vietnamese pharmaceutical company specializing in branded traditional medicines and OTC products with its own nationwide distribution network — directly comparable to DHG in geography, product mix, and distribution model.
• Imexpharm Corporation: Imexpharm is a HOSE-listed Vietnamese generic pharmaceutical manufacturer with manufacturing and pharmacy distribution operations, directly comparable to DHG in product categories (cardiovascular, antibiotics, OTC) and customer base.
• Duc Long Pharmaceutical JSC (DCL Pharma): Dược Cửu Long is a HOSE-listed Vietnamese pharma manufacturer producing generic and OTC medicines with national distribution — directly comparable to DHG in product portfolio and channel coverage.
• OPC Pharmaceutical JSC: OPC Pharmaceutical is a Vietnamese generic pharma manufacturer producing essential medicines across multiple therapeutic areas and distributing through Vietnamese pharmacy networks — closely comparable to DHG's broad generic portfolio.
• Mekophar Chemical Pharmaceutical JSC: Mekophar is a HOSE-listed Vietnamese manufacturer of chemical pharmaceuticals, antibiotics, and essential medicines, comparable to DHG as a domestic generic pharma peer serving the same Vietnamese hospital and pharmacy channels.

Broad incumbents

• Bayer Vietnam: Bayer is a global pharmaceutical and consumer health incumbent with established distribution in Vietnam, competing with DHG in OTC and supplement segments through brands like Berocca and Supradyn.
• Sanofi Vietnam: Sanofi operates one of the largest multinational pharmaceutical footprints in Vietnam across prescription, vaccines, and consumer health, representing a broad incumbent competing with DHG in OTC and prescription categories.

Emerging players

• Sun Pharma (India): Sun Pharma is a major Indian generic manufacturer expanding into Southeast Asian markets including Vietnam; an emerging competitor and benchmark for DHG on generic manufacturing scale and export potential.

Others

• Taisho Pharmaceutical Co. Ltd. Taisho Pharmaceutical is a Japanese OTC-focused pharmaceutical company; based on the Japanese-named legal representative at DHG, Taisho is understood to be a strategic shareholder, making it the most directly relevant foreign strategic counterpart.

Market position

Strengths2 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@dhgpharma-vimotcuocsongkho4451
• Facebookfacebook.com/duochaugiang
• LinkedInlinkedin.com/company/dhg-pharmaceuticals

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DHG Pharma